Skip to main content

ORIGINAL RESEARCH article

Front. Cell Dev. Biol., 05 February 2021
Sec. Cell Death and Survival
This article is part of the Research Topic Dynamical Networks of Life/Death Decisions in a Cell: From DNA Repair to Cell Death View all 19 articles

RETRACTED: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway

Retracted
\r\nLi-Mei Wu&#x;Li-Mei Wu1Xiao-Zhong Liao&#x;Xiao-Zhong Liao2Yan Zhang&#x;Yan Zhang1Zi-Rui HeZi-Rui He1Shi-Qing NieShi-Qing Nie1Bin KeBin Ke3Lin ShiLin Shi4Jian-Fu Zhao
Jian-Fu Zhao1*Wen-Hui Chen
Wen-Hui Chen1*
  • 1Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, China
  • 2Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
  • 3Department of Traditional Chinese Medicine, Cancer Center of Sun Yat-sen University, Guangzhou, China
  • 4Department of Traditional Chinese Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China

Citation: Wu L-M, Liao X-Z, Zhang Y, He Z-R, Nie S-Q, Ke B, Shi L, Zhao J-F and Chen W-H (2021) Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway. Front. Cell Dev. Biol. 8:610097. doi: 10.3389/fcell.2020.610097

Received: 25 September 2020; Accepted: 30 November 2020;
Published: 05 February 2021; Retracted: 05 May 2021.

Edited by:

Inna N. Lavrik, University Hospital Magdeburg, Germany

Reviewed by:

Jiaxing Zhang, Sun Yat-sen University, China
Mario Cioce, Campus Bio-Medico University, Italy

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.